Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$5.07K Buy
20
+6
+43% +$1.51K ﹤0.01% 1216
2025
Q3
$3.46K Buy
14
+6
+75% +$1.44K ﹤0.01% 1213
2025
Q2
$1.94K Buy
8
+3
+60% +$699 ﹤0.01% 1242
2025
Q1
$1.13K Sell
5
-335
-99% -$73.7K ﹤0.01% 1153
2024
Q4
$69.9K Sell
340
-6
-2% -$1.32K 0.01% 496
2024
Q3
$83.9K Hold
346
0.01% 419
2024
Q2
$75.6K Buy
+346
New +$75.2K 0.01% 690
2023
Q4
Sell
-324
Closed -$71.1K 1329
2023
Q3
$71.1K Sell
324
-12
-4% -$2.71K 0.02% 461
2023
Q2
$73.6K Buy
+336
New +$67.2K 0.01% 589

Other funds holding STE

ORG Partners's STE Position: Q4 2025 in Review

ORG Partners increased its Steris (STE) stake by 43% in Q4 2025, buying an estimated $1.51K and bringing the position to 20 shares worth $5.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

ORG Partners first reported a position in STE in Q2 2023 and has held it in 9 quarters since. The position peaked at $83.9K in Q3 2024. 894 funds tracked by Wall St. Rank hold STE as of Q4 2025.

  • ORG Partners held 20 shares of Steris worth $5.07K as of Q4 2025.
  • ORG Partners bought 6 Steris shares in Q4 2025, an estimated $1.51K.
  • Steris made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1216 holding.
  • ORG Partners first reported a position in Steris in Q2 2023 and has held it in 9 quarters since.
  • ORG Partners's Steris position peaked at $83.9K in Q3 2024.
  • 894 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.